IDEX has delivered strong shareholder returns recently, which puts a spotlight on whether the current share price matches the cash flows the business is expected to produce. With the stock now reflecting a confident market view, the key issue is how that optimism lines up with its intrinsic value based on cash generation.
The issue now is whether IDEX’s current share price around US$232.91 is justified by the cash flows implied by its Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing IDEX against other opportunities that also focus on valuation and cash generation, it can help to compare it directly with 29 high quality undervalued stocks.
The Discounted Cash Flow (DCF) model here is built around what IDEX can return to shareholders through future free cash flow. Latest twelve month free cash flow is about $641.9 million, which gives the valuation a solid current cash base rather than relying only on distant projections.
Analysts feeding into this DCF expect IDEX’s free cash flow to be growing over the next decade, with projected annual figures rising into the mid single digit growth range in later years. Those future cash streams are then discounted back and compared with today’s share price of $232.91, and on that measure the projections put IDEX's estimated intrinsic value meaningfully above the current share price. That difference is what readers can explore in more detail through the full calculation. Find out what IDEX could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives for IDEX pick up where the DCF puzzle leaves off by spelling out what would need to happen to growth, margins and earnings for the shares to be worth meaningfully more or less than today’s price. Each narrative ties a fair value estimate to a particular storyline about IDEX's potential catalysts and key risks, so you can track over time which version of events seems closest to reality on the Community page.
One of the top community narratives on IDEX: 9% undervalued
"Record company backlog of more than US$1b with 28% organic order growth in Q2 2026 and multi quarter visibility in HST and parts of FMT..."
Discover why this Narrative puts IDEX at 9% undervalued.
Before making a call on IDEX, it helps to look at who is steering the business, how their incentives are structured, and whether those rewards line up with your own goals. See who runs IDEX and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com